Dechert Advises Mauna Kea Technologies on Refinancing

"Dechert advised Mauna Kea Technologies on a refinancing following a sauvegarde proceeding under the regime of classes of affected creditors. The operation combined a significant debt reduction through collective procedures with securities issuances that raised €6.1 million, enabling the company to focus on sales growth and a path to profitability."

Dechert advised Mauna Kea Technologies, inventor of the Cellvizio® endomicroscopy platform, in connection with its refinancing following a sauvegarde proceeding under the regime of classes of affected creditors. The transaction implemented an innovative restructuring that combined a substantial reduction of Mauna Kea Technologies’ debt through the leverage of collective insolvency procedures under the classes of affected creditors regime with several issuances of securities that provided new financing totalling €6.1 million. This package is intended to stabilise the company’s balance sheet and allow management to concentrate on growing sales and achieving profitability. Dechert represented Mauna Kea Technologies with a team composed by: Vianney Toulouse, assisted by Mathilde Duchamp and Yona Elfassi of the M&A/Capital Markets team dedicated to life sciences, under the responsibility of Alain Decombe.

Dechert Advises Mauna Kea Technologies on Refinancing

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads